Suzanne U. Emerson
45Patents
7h-index
34Co-inventors
69Inventor score
Filing activity: Jul 12, 1988 → Jan 20, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6153421A | Cloned genomes of infectious hepatitis C viruses and uses thereof | Chemistry; Metallurgy | 33 | Expired |
| US5284760A | Techniques for producing site-directed mutagenesis of cloned DNA | Chemistry; Metallurgy | 25 | Expired |
| US4894228A | Vaccine against hepatitis A virus | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6180110A | Attenuated hepatitis a virus vaccine which grows in MRC-5 cells | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6287759A | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6113912A | Hepatitis A virus vaccines | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7084266B1 | Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof | Chemistry; Metallurgy | 7 | Expired |
| US5849562A | Production of complementary DNA representing hepatitis A viral sequences by recombinant DNA methods and uses therefor | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6423318B1 | Hepatitis A virus vaccines | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6054567A | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines | Physics | 6 | Expired |
| US5476658A | Vaccine against hepatitis a comprising simian HAV isolate AGM-27 | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7282205B2 | Anti-hepatitis A virus antibodies | Chemistry; Metallurgy | 4 | Expired |
| US7678569B2 | Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof | Physics | 2 | Active |
| US7201911B1 | Cloned genomes of infectious hepatitis C viruses and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US6432408B1 | Swine hepatitis E virus and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US7009044B1 | HCV/BVDV chimeric genomes and uses thereof | Chemistry; Metallurgy | 2 | Expired |
| US7914788B2 | Monoclonal antibodies against orthopoxviruses | Physics | 2 | Active |
| US8961975B2 | Monoclonal antibodies that neutralize anthrax toxins | Physics | 1 | Active |
| US6156499A | Methods for detecting antibodies to HAV 3C proteinase | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8574853B2 | Monoclonal antibodies that neutralize anthrax toxins | Physics | 1 | Active |
| US8071100B2 | Monoclonal antibodies that neutralize anthrax toxins | Physics | 1 | Active |
| US7129342B1 | Infectious cDNA clone of GB virus B and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US9580492B2 | Monoclonal antibodies that neutralize anthrax toxins | Physics | 1 | Active |
| US6146643A | Human/simian chimeric hepatitis A virus vaccine | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6207416A | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.